Healthcare · NSE: GLAXO
GlaxoSmithKline Pharmaceuticals Limited
₹2,498.00
+1.04% · close 28 Oct 2026
52-week range
₹2,103.20 – ₹3,106.40
From 52W high
-19.59%
Return 1Y
-6.02%
Volume · Avg 20D
24,842 · 46,628
Returns & technicals
1W+1.36%
1M-11.28%
3M-5.11%
6M+2.41%
1Y-6.02%
| 50-day average | ₹2,777.16 below |
| 200-day average | ₹2,512.92 below |
| Volatility (1Y, annualised) | 26.25% |
| RSI (14) | 38.3 |
| MACD histogram (12, 26, 9) | -2.09 |
| Delivery · 20D avg | 57.53% · 49.21% |
| Turnover (last day) | ₹6 Cr |
Profile
| Symbol | GLAXO |
| ISIN | INE159A01016 |
| Sector | Healthcare |
| Listed on NSE | 15 Dec 2000 |
| Face value | ₹10 |
| Series | EQ |
Financials & shareholding
Quarterly results, P/E and the shareholding pattern for GLAXO are coming in a later update.
Peers in Healthcare
| Stock | Price | Day | 1M | 1Y |
|---|---|---|---|---|
| PPLPHARMA Piramal Pharma Limited | ₹232.80 | +17.15% | +10.69% | +15.19% |
| SYNGENE Syngene International Limited | ₹410.85 | +12.19% | +8.49% | -37.51% |
| ACUTAAS Acutaas Chemicals Limited | ₹3,710.00 | -2.20% | +13.37% | +116.38% |
| DIVISLAB Divi's Laboratories Limited | ₹9,558.50 | +0.56% | -0.63% | +48.46% |
| ONESOURCE Onesource Specialty Pharma Limited | ₹1,577.60 | -0.77% | -1.56% | -14.00% |
| APOLLOHOSP Apollo Hospitals Enterprise Limited | ₹8,137.00 | +4.43% | -8.46% | +3.25% |